Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
Tisi MC, Cupelli E, Santangelo R, Maiolo E, Alma E, Giachelia M, Martini M, Bellesi S, D'Alò F, Voso MT, Pompili M, Leone G, Larocca LM, Hohaus S. Tisi MC, et al. Among authors: alma e. Leuk Lymphoma. 2016;57(3):628-34. doi: 10.3109/10428194.2015.1072766. Epub 2015 Oct 12. Leuk Lymphoma. 2016. PMID: 26458141
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI).
Annibali O, Hohaus S, Marchesi F, Cantonetti M, Di Rocco A, Tomarchio V, Di Napoli A, Pelliccia S, Battistini R, Anticoli Borza P, Abruzzese E, Cenfra N, Andriani A, Tesei C, Alma E, Palombi F, Pupo L, Petrucci L, Becilli M, Maiolo E, Bellesi S, Cuccaro A, D'Alò F, Cox MC. Annibali O, et al. Among authors: alma e. Leuk Lymphoma. 2019 Dec;60(14):3386-3394. doi: 10.1080/10428194.2019.1633628. Epub 2019 Jul 1. Leuk Lymphoma. 2019. PMID: 31259651
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma.
Cuccaro A, Bellesi S, Galli E, Zangrilli I, Corrente F, Cupelli E, Fatone F, Maiolo E, Alma E, Viscovo M, D'Alò F, Annunziata S, Martini M, Rufini V, Giordano A, De Stefano V, Larocca LM, Hohaus S. Cuccaro A, et al. Among authors: alma e. J Leukoc Biol. 2022 Sep;112(3):539-545. doi: 10.1002/JLB.5AB0121-041R. Epub 2022 Jan 20. J Leukoc Biol. 2022. PMID: 35060170 Free PMC article.
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment.
Bellesi S, Sali M, Maiolo E, Pereyra Boza MDC, Alma E, Palucci I, Fatone F, De Maio F, Viscovo M, D'Alò F, De Stefano V, Hohaus S, Sanguinetti M. Bellesi S, et al. Among authors: alma e. Leuk Lymphoma. 2022 Jun;63(6):1474-1478. doi: 10.1080/10428194.2022.2032042. Epub 2022 Feb 1. Leuk Lymphoma. 2022. PMID: 35105258 No abstract available.
Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement.
Cappannoli L, Imazio M, Hohaus S, Saponara G, D'Amario D, Bellesi S, Maiolo E, Viscovo M, Fatone F, Alma E, D'Alò F, Crea F, Sanna T. Cappannoli L, et al. Among authors: alma e. Front Cardiovasc Med. 2022 Nov 7;9:1000259. doi: 10.3389/fcvm.2022.1000259. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36419498 Free PMC article.
45 results